Stem cell clinic Scottsdale: what may ease the ache?

How does ordinary joint wear usually feel?

A worn knee may ache more during stairs or a longer walk. A hip may hurt when you rise from a chair. Your shoulder may complain when the arm reaches overhead. Each joint has its own motions that bring out soreness.

Arthritis can make a joint stiff after you have been sitting. Gentle motion may ease that stiffness for a time. Swelling can follow a busy day, then settle as the joint rests. Have growing soreness examined instead of waiting for it to settle.

What may calm the soreness at home?

Do less of the motion that started the ache, but don't stop all movement. Easy bending and straightening can keep stiffness from taking hold. Stop when the joint feels weak or unsafe, and use exercises chosen by your own doctor.

Notice what makes the joint hurt and when it settles. Write down the task, the sore area, and any swelling. Keep the notes where you'll see them because they show whether gentler movement helps. This record also makes an office visit easier to explain.

When does the joint need an exam?

Seek care soon if the joint becomes hot or badly swollen. A fever alongside that heat and swelling needs quick medical help. New weakness or a sudden inability to stand also needs care. Those signs aren't part of a usual sore day.

Ongoing soreness calls for questions about movement, rest, and swelling. Medical providers are the trained people who check your joint and direct care. Their exam covers motion, strength, and the exact sore area. QC Kinetix offers PRP, or platelet-rich plasma, made by concentrating part of your blood and placed at the joint as a non-surgical regenerative treatment.

Sources

1. FDA states in its consumer alert that the only FDA-approved stem cell products in the United States are blood-forming stem cells derived from umbilical cord blood, approved for disorders of the blood-forming system, and that NONE of these products - stem cells, stromal vascular fraction, umbilical cord blood, Wharton's jelly or amniotic fluid - has been approved for the treatment of any orthopedic condition, including osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain or shoulder pain.

   US Food and Drug Administration, Center for Biologics Evaluation and Research — Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes. , 2020.

2. In orders issued 26 December 2024 and announced 8 January 2025, a federal court permanently banned the co-founders of the Stem Cell Institute of America and their companies from marketing any regenerative medicine treatment, and ordered $5,155,146 in refunds and civil penalties. The court found on summary judgment that they published false and misleading advertisements about the efficacy and approval of stem cell injections for osteoarthritis, neuropathy and joint pain; their clinic charged up to $5,000 per injection and the customers were almost exclusively elderly and disabled people.

   US Federal Trade Commission — Stem Cell Institute Co-Founders and Companies Banned from Marketing Stem Cell Treatments and Ordered to Pay More Than $5.1 Million for Refunds and Civil Penalties. , 2025.

3. An analysis of 38 businesses advertising stem cell and exosome products for COVID-19 found listed prices from $2,950 to $25,000 with an average of $11,322 - a direct measure of what this marketplace charges for products with no regulatory approval.

   Turner L, et al. — Businesses marketing purported stem cell treatments and exosome therapies for COVID-19: An analysis of direct-to-consumer online advertising claims. Stem Cell Reports, 2023. DOI: 10.1016/j.stemcr.2023.09.015.

4. In a 480-patient, four-arm, multicenter randomized phase 2/3 trial, none of three orthobiologic cell injections - autologous bone marrow aspirate concentrate, autologous adipose stromal vascular fraction, or allogeneic umbilical cord tissue-derived mesenchymal stromal cells - was superior to any other, or to a corticosteroid injection control, on pain at 12 months.

   Mautner K, et al. — Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial. Nat Med, 2023. DOI: 10.1038/s41591-023-02632-w.